Merkel cell carcinoma (MCC)

A 55-year-old male truck driver with hypertension and type 2 diabetes had a history remarkable for a mass of the right groin, treated with surgical excision. Fourteen months after resection of the mass, the patient was seen in the urgent care clinic for cough. Chest radiographs were normal and he was treated for bronchitis and released. Returning 1 month later, he observed that a "knot" had developed on his head after a blow to the parietal area. Physical examination showed an approximately 2-cm firm discoid nodule of the right occipitoparietal area. The "knot" was thought to be a calcified hematoma and the patient was told to seek follow-up care if the nodule changed. Four months later, he returned with complaint of a dry cough and variable headaches and incidentially requested an examination of the "knot" again. The scalp lesion had grown and was now boggy to palpation. All laboratory data was normal.

COMMENTS comments

Share your thoughts.
Post a comment →
Read Comments(0) →
Article Tools Sponsored By
Loading...
Diagnosis
Merkel cell carcinoma (MCC)
Discussion
Merkel cell carcinoma, also called cutaneous small cell undifferentiated carcinoma, is an exceedingly rare entity of unknown incidence. Arising from neuroendocrine (or Merkel cells) in the dermis, MCC is thought to share neural crest origins with malignant melanoma, pheochromocytoma, and neuroblastoma. MCC is relentlessly progressive, with lymphatic and, less commonly, hematogeneous spread. Mean time to recurrence is reported to be 8 to 10 months and the 3-year survival rate is 55% to 58%.1-3 Only nine cases of brain metastases have been reported to date. This case presentation graphically illustrates the intensely aggressive nature of this malignancy.

Clinically, MCC may present as a "solitary violaceous dome shaped nodule or indurated plaque."3 On microscopy, immunohistologic examination demonstrates epithelial (cytokeratins, epithelial membrane antigen) and neuroendocrine (neuron-specific enolase, chromogranin A) markers, confirming diagnosis.2

While radiography is not diagnostic for MCC, CT imaging of primary lesions reveals solitary or multiple minimally enhancing soft-tissue nodules, which may be associated with lytic bony erosion.4 Lesions are hyper- or isodense in relation to muscle.5 Metastatic lesions demonstrate target-shaped lesions with or without ring enhancement;4 and subcutaneous linear stranding.5 MCC lesions are hypoechoic on sonography. CT has proven useful in staging disease,5 as has lymphatic mapping of sentinel nodes by scintigraphy.

Truncal location,1 size >2 cm, male sex, positive surgical margins, positive nodes,1,2 and second primary tumor2 are associated with the least favorable prognosis. Wide surgical excision and lymphadenectomy with local radiation is the treatment of choice1-3 with adjuvant chemotherapy in selected cases.1-3 Octreotide and natural human tumor necrosis factor have shown promise in limited trials.6-8

Interestingly, the literature documents a disproportionate number of spontaneous remissions occurring in this otherwise devastating disease; the usual incidence of spontaneously remitting carcinoma is less than 1 in 60,000 to 100,000 cases. Two sources suggest that regression of the lesions may be associated with dense lymphocytic infiltrates and apoptosis of peripheral cells in tumor nests.9,10

ACKNOWLEDGMENT

The authors wish to thank Dr. A. Singh, Laboratory Chief; Dr. P. Katikaneni, Department of Pathology; and John Baroody, Medical Photographer; at the Ralph H. Johnson VA Medical Center for their assistance in preparing this report.



  1. Ott JM, Tanabe KK, Gadd MA, et al: Multimodality management of Merkel cell carcinoma. Arch Surg 134:388-392; discussion 392-392, 1999.
  2. Fenig E, Brenner B, Katz A, et al: The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 80:881-885, 1997.
  3. Verola A, Champeau F: Merkel cell carcinoma [in French]. Ann Chir Plast Esthet 43:439-444, 1998.
  4. 4. Eftekhari F, Wallace S, Silva EG, Lenzi R: Merkel cell carcinoma of the skin: Imaging and clinical features in 93 cases. Br J Radiol 69:226-233, 1996.
  5. Gollub MJ, Gruen DR, Dershaw DD: Merkel cell carcinoma: CT findings in 12 patients. AJR Am J Roentgenol 167:617-620, 1996.
  6. DelRio P, Borgia GL, Lampugnani R: Merkel cell carcinoma: A report of 3 clinical cases. Min Chiurg 54:179-183, 1999.
  7. Cirullo F, Filippini L, Lima GF, et al: Merkel cell tumor: Report of case and treatment with octreotide. Min Chiurg 52:1359-1365, 1997.
  8. Hata Y, Matsuka K, Ito O, et al: Two cases of Merkel cell carcinoma cured by intratumor injection of natural human tumor necrosis factor. Plast Reconst Surg 99:547-553, 1997.
  9. Takenake H, Kishimoto S, Shibaki R, et al: Merkel cell carcinoma with partial spontaneous regression: An immunohistochemical, ultrastructural, and TUNEL labeling study. Am J Dermatopathol 19:614-618, 1997.
  10. Kayashima K, Ono T, Johno M, et al: Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of skin. Arch Dermatol 127:550-553, 1991.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1